메뉴 건너뛰기




Volumn 10, Issue 4, 2015, Pages

Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia

(21)  Cesano, Alessandra a   Willman, Cheryl L b   Kopecky, Kenneth J c   Gayko, Urte a   Putta, Santosh a   Louie, Brent a   Westfall, Matt a   Purvis, Norman a   Spellmeyer, David C a   Marimpietri, Carol a   Cohen, Aileen C a   Hackett, James a   Shi, Jing a   Walker, Michael G a   Sun, Zhuoxin d   Paietta, Elisabeth e   Tallman, Martin S f   Cripe, Larry D g   Atwater, Susan h   Appelbaum, Frederick R c   more..


Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; TUMOR MARKER; ANTINEOPLASTIC AGENT;

EID: 84929471466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118485     Document Type: Article
Times cited : (5)

References (35)
  • 1
    • 77957724998 scopus 로고    scopus 로고
    • Shortcomings in the clinical evaluation of new drugs: Acute myeloid leukemia as paradigm
    • PMID: 20538802
    • Walter RB, Appelbaum FR, Tallman MS, Weiss NS, Larson RA, et al. (2010) Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm. Blood 116: 2420-2428. doi: 10.1182/blood-2010-05-285387 PMID: 20538802
    • (2010) Blood , vol.116 , pp. 2420-2428
    • Walter, R.B.1    Appelbaum, F.R.2    Tallman, M.S.3    Weiss, N.S.4    Larson, R.A.5
  • 2
    • 33751267902 scopus 로고    scopus 로고
    • Acute myeloid leukaemia
    • PMID: 17126723
    • Estey E, Dohner H (2006) Acute myeloid leukaemia. Lancet 368: 1894-1907. PMID: 17126723
    • (2006) Lancet , vol.368 , pp. 1894-1907
    • Estey, E.1    Dohner, H.2
  • 3
    • 0345104178 scopus 로고    scopus 로고
    • Double induction strategy for acute myeloid leukemia: The effect of high-dose cytarabine with mitoxantrone instead of standarddose cytarabine with daunorubicin and 6-thioguanine: A randomized trial by the German AML Cooperative Group
    • PMID: 10361108
    • Buchner T, Hiddemann W, Wormann B, Loffler H, Gassmann W, et al. (1999) Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standarddose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood 93: 4116-4124. PMID: 10361108
    • (1999) Blood , vol.93 , pp. 4116-4124
    • Buchner, T.1    Hiddemann, W.2    Wormann, B.3    Loffler, H.4    Gassmann, W.5
  • 4
    • 70349451999 scopus 로고    scopus 로고
    • High-dose daunorubicin in older patients with acute myeloid leukemia
    • PMID: 19776405
    • Lowenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, et al. (2009) High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 361: 1235-1248. doi: 10.1056/NEJMoa0901409 PMID: 19776405
    • (2009) N Engl J Med , vol.361 , pp. 1235-1248
    • Lowenberg, B.1    Ossenkoppele, G.J.2    Van Putten, W.3    Schouten, H.C.4    Graux, C.5
  • 5
    • 78650171819 scopus 로고    scopus 로고
    • Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: A web-based application for prediction of outcomes
    • PMID: 21131036
    • Krug U, Rollig C, Koschmieder A, Heinecke A, Sauerland MC, et al. (2010) Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. Lancet 376: 2000-2008. doi: 10.1016/S0140-6736(10)62105-8 PMID: 21131036
    • (2010) Lancet , vol.376 , pp. 2000-2008
    • Krug, U.1    Rollig, C.2    Koschmieder, A.3    Heinecke, A.4    Sauerland, M.C.5
  • 6
    • 1542753559 scopus 로고    scopus 로고
    • Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
    • Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, et al. (2003) Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 21: 4642-4649.
    • (2003) Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology , vol.21 , pp. 4642-4649
    • Cheson, B.D.1    Bennett, J.M.2    Kopecky, K.J.3    Buchner, T.4    Willman, C.L.5
  • 8
    • 84929481594 scopus 로고    scopus 로고
    • Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: Results from single cell network profiling studies
    • Cesano A, Perbellini O, Evensen E, Chu CC, Cioffi F, et al. (2012) Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies. Haematologica.
    • (2012) Haematologica
    • Cesano, A.1    Perbellini, O.2    Evensen, E.3    Chu, C.C.4    Cioffi, F.5
  • 9
    • 84879843884 scopus 로고    scopus 로고
    • Development and Validation of a Single-Cell Network Profiling (SCNP) Assay-based Classifier to Predict Response to Induction Therapy in Pediatric Patients with de novo Acute Myeloid Leukemia (AML): A Report from the Children's Oncology Group
    • Lacayo N, Alonzo TA, Gayko U, Rosen DB, Westfall M, et al. (2013) Development and Validation of a Single-Cell Network Profiling (SCNP) Assay-based Classifier to Predict Response to Induction Therapy in Pediatric Patients with de novo Acute Myeloid Leukemia (AML): A Report from the Children's Oncology Group British Journal of Haematology.
    • (2013) British Journal of Haematology
    • Lacayo, N.1    Alonzo, T.A.2    Gayko, U.3    Rosen, D.B.4    Westfall, M.5
  • 10
    • 84874203549 scopus 로고    scopus 로고
    • Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational status
    • PMID: 23431389
    • Cesano A, Putta S, Rosen DB, Cohen AC, Gayko U, et al. (2013) Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational status. PLoS ONE 8: e56714. doi: 10.1371/journal.pone.0056714 PMID: 23431389
    • (2013) PLoS ONE , vol.8 , pp. e56714
    • Cesano, A.1    Putta, S.2    Rosen, D.B.3    Cohen, A.C.4    Gayko, U.5
  • 11
    • 78149431428 scopus 로고    scopus 로고
    • Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP)
    • PMID: 21048955
    • Rosen DB, Minden MD, Kornblau SM, Cohen A, Gayko U, et al. (2010) Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP). PLoS ONE 5: e13543. doi: 10.1371/journal.pone.0013543 PMID: 21048955
    • (2010) PLoS ONE , vol.5 , pp. e13543
    • Rosen, D.B.1    Minden, M.D.2    Kornblau, S.M.3    Cohen, A.4    Gayko, U.5
  • 12
    • 0032525248 scopus 로고    scopus 로고
    • A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: A Southwest oncology group study (9031)
    • PMID: 9572995
    • Godwin JE, Kopecky KJ, Head DR, Willman CL, Leith CP, et al. (1998) A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031). Blood 91: 3607-3615. PMID: 9572995
    • (1998) Blood , vol.91 , pp. 3607-3615
    • Godwin, J.E.1    Kopecky, K.J.2    Head, D.R.3    Willman, C.L.4    Leith, C.P.5
  • 13
    • 0036892524 scopus 로고    scopus 로고
    • Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: A Southwest Oncology Group study
    • PMID: 12393614
    • Anderson JE, Kopecky KJ, Willman CL, Head D, O'Donnell MR, et al. (2002) Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study. Blood 100: 3869-3876. PMID: 12393614
    • (2002) Blood , vol.100 , pp. 3869-3876
    • Anderson, J.E.1    Kopecky, K.J.2    Willman, C.L.3    Head, D.4    O'Donnell, M.R.5
  • 14
    • 72549101193 scopus 로고    scopus 로고
    • Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia
    • PMID: 19821823
    • Chauncey TR, Gundacker H, Shadman M, List AF, Dakhil SR, et al. (2010) Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia. British Journal of Haematology 148: 48-58. doi: 10.1111/j.1365-2141.2009.07919.x PMID: 19821823
    • (2010) British Journal of Haematology , vol.148 , pp. 48-58
    • Chauncey, T.R.1    Gundacker, H.2    Shadman, M.3    List, A.F.4    Dakhil, S.R.5
  • 15
    • 9144238671 scopus 로고    scopus 로고
    • A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: A trial by the Eastern Cooperative Oncology Group
    • PMID: 14512295
    • Rowe JM, Neuberg D, Friedenberg W, Bennett JM, Paietta E, et al. (2004) A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group. Blood 103: 479-485. PMID: 14512295
    • (2004) Blood , vol.103 , pp. 479-485
    • Rowe, J.M.1    Neuberg, D.2    Friedenberg, W.3    Bennett, J.M.4    Paietta, E.5
  • 16
    • 78549238612 scopus 로고    scopus 로고
    • Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: A randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999
    • PMID: 20716770
    • Cripe LD, Uno H, Paietta EM, Litzow MR, Ketterling RP, et al. (2010) Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. Blood 116: 4077-4085. doi: 10.1182/blood-2010-04-277269 PMID: 20716770
    • (2010) Blood , vol.116 , pp. 4077-4085
    • Cripe, L.D.1    Uno, H.2    Paietta, E.M.3    Litzow, M.R.4    Ketterling, R.P.5
  • 17
    • 0016799829 scopus 로고
    • Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
    • PMID: 1100130
    • Pocock SJ, Simon R (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31: 103-115. PMID: 1100130
    • (1975) Biometrics , vol.31 , pp. 103-115
    • Pocock, S.J.1    Simon, R.2
  • 18
    • 84929481595 scopus 로고    scopus 로고
    • Single cell network profiling (SCNP) functionally characterizes FLT3 pathway deregulation in non-M3 acute myeloid leukemia (AML) and provides prognostic value independent from mutational status
    • ASH Annual Meeting Abstracts
    • Cesano A, Putta S, Mathi K, Rosen DB, Gayko U, et al. (2011) Single cell network profiling (SCNP) functionally characterizes FLT3 pathway deregulation in non-M3 acute myeloid leukemia (AML) and provides prognostic value independent from mutational status. Blood (ASH Annual Meeting Abstracts) 118: Abstract 2512.
    • (2011) Blood , vol.118
    • Cesano, A.1    Putta, S.2    Mathi, K.3    Rosen, D.B.4    Gayko, U.5
  • 19
    • 53049110682 scopus 로고    scopus 로고
    • MIFlowCyt: The minimum information about a Flow Cytometry Experiment
    • PMID: 18752282
    • Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, et al. (2008) MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A 73: 926-930. doi: 10.1002/cyto.a.20623 PMID: 18752282
    • (2008) Cytometry A , vol.73 , pp. 926-930
    • Lee, J.A.1    Spidlen, J.2    Boyce, K.3    Cai, J.4    Crosbie, N.5
  • 20
    • 84863393783 scopus 로고    scopus 로고
    • Functional pathway analysis in acute myeloid leukemia using Single Cell Network Profiling (SCNP) assay: Effect of specimen source (bone marrow or peripheral blood) on assay readouts
    • PMID: 22334473
    • Cesano A, Rosen DB, O'Meara P, Putta S, Gayko U, et al. (2012) Functional pathway analysis in acute myeloid leukemia using Single Cell Network Profiling (SCNP) assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts. Cytometry Part B 82: 158-172. doi: 10.1002/cyto.b.21007 PMID: 22334473
    • (2012) Cytometry Part B , vol.82 , pp. 158-172
    • Cesano, A.1    Rosen, D.B.2    O'Meara, P.3    Putta, S.4    Gayko, U.5
  • 21
    • 77952568988 scopus 로고    scopus 로고
    • L1 penalized estimation in the Cox proportional hazards model
    • PMID: 19937997
    • Goeman JJ (2010) L1 penalized estimation in the Cox proportional hazards model. Biometrical journal Biometrische Zeitschrift 52: 70-84. doi: 10.1002/bimj.200900028 PMID: 19937997
    • (2010) Biometrical Journal Biometrische Zeitschrift , vol.52 , pp. 70-84
    • Goeman, J.J.1
  • 22
    • 0035478854 scopus 로고    scopus 로고
    • Random Forests
    • Breiman L (2001) Random Forests. Machine Learning 45: 5-32.
    • (2001) Machine Learning , vol.45 , pp. 5-32
    • Breiman, L.1
  • 24
    • 0002178053 scopus 로고
    • Bias Reduction of Maximum Likelihood Estimates
    • Firth D (1993) Bias Reduction of Maximum Likelihood Estimates. Biometrika 80: 41.
    • (1993) Biometrika , vol.80 , pp. 41
    • Firth, D.1
  • 26
    • 0345040873 scopus 로고    scopus 로고
    • Classifications and Regression by random Forest
    • Law A, and, Wiener M (2002) Classifications and Regression by random Forest. R News.
    • (2002) R News
    • Law, A.1    Wiener, M.2
  • 28
    • 0036630603 scopus 로고    scopus 로고
    • Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: Statistical significance and interpretation
    • Mason SJG, N.E. (2002) Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: Statistical significance and interpretation. Q J R Meteorological Society 128: 21.
    • (2002) Q J R Meteorological Society , vol.128 , pp. 21
    • Mason, S.J.G.1    N, E.2
  • 29
    • 0031858636 scopus 로고    scopus 로고
    • Confidence intervals for the receiver operating characteristic area in studies with small samples
    • PMID: 9702267
    • Obuchowski NA, Lieber ML (1998) Confidence intervals for the receiver operating characteristic area in studies with small samples. Academic radiology 5: 561-571. PMID: 9702267
    • (1998) Academic Radiology , vol.5 , pp. 561-571
    • Obuchowski, N.A.1    Lieber, M.L.2
  • 30
    • 84876432422 scopus 로고    scopus 로고
    • Single cell network profiling (SCNP)-based classifier to predict response to induction therapy in pediatric patients with de novo acute myeloid leukemia (AML): Validation study results
    • ASH Annual Meeting Abstracts
    • Lacayo NJ, Alonzo TA, Gayko U, Westfall M, Purvis N, et al. (2011) Single cell network profiling (SCNP)-based classifier to predict response to induction therapy in pediatric patients with de novo acute myeloid leukemia (AML): validation study results. Blood (ASH Annual Meeting Abstracts) 118: Abstract 3544.
    • (2011) Blood , vol.118
    • Lacayo, N.J.1    Alonzo, T.A.2    Gayko, U.3    Westfall, M.4    Purvis, N.5
  • 32
    • 0035469883 scopus 로고    scopus 로고
    • The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
    • PMID: 11520776
    • Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, et al. (2001) The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98: 1312-1320. PMID: 11520776
    • (2001) Blood , vol.98 , pp. 1312-1320
    • Grimwade, D.1    Walker, H.2    Harrison, G.3    Oliver, F.4    Chatters, S.5
  • 34
    • 84863398978 scopus 로고    scopus 로고
    • Sample Cryopreservation Does Not Affect Functional Read Outs In SCNP Assays: Implications for Biomarker Development
    • ASH Annual Meeting Abstracts
    • Cesano A, Gotlib JR, Lacayo NJ, Putta S, Lackey A, et al. (2010) Sample Cryopreservation Does Not Affect Functional Read Outs In SCNP Assays: Implications for Biomarker Development. Blood (ASH Annual Meeting Abstracts) 116: 4843.
    • (2010) Blood , vol.116 , pp. 4843
    • Cesano, A.1    Gotlib, J.R.2    Lacayo, N.J.3    Putta, S.4    Lackey, A.5
  • 35
    • 84867490138 scopus 로고    scopus 로고
    • Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML
    • PMID: 23063124
    • Vo TT, Ryan J, Carrasco R, Neuberg D, Rossi DJ, et al. (2012) Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 151: 344-355. doi: 10.1016/j.cell.2012.08.038 PMID: 23063124
    • (2012) Cell , vol.151 , pp. 344-355
    • Vo, T.T.1    Ryan, J.2    Carrasco, R.3    Neuberg, D.4    Rossi, D.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.